Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.06.2012 | main topic | Ausgabe 11-12/2012

Wiener Medizinische Wochenschrift 11-12/2012

TBE—update on vaccination recommendations for children, adolescents, and adults

Zeitschrift:
Wiener Medizinische Wochenschrift > Ausgabe 11-12/2012
Autor:
MD, PhD, DTM&H Tomas Jelinek

Summary

Vaccines against tick-born encephalitis (TBE) are well established in Europe. Two highly immunogenic and safe products are available, FSME-IMMUN and Encepur. Extensive research has been published regarding all aspects of standard and rapid immunization schedules, covaccination, and vaccine interchangeability. Long-term effectiveness and resulting recommendations for booster intervals remain topics of discussion. Vaccination is recommended in Switzerland and in Germany for adults and children living in, or travelling to, endemic areas. Austria has recommended universal vaccination since 1981. It is noteworthy that Austria is the only country in Europe that has experienced a decrease in caseload during the last 20 years. This is almost certainly due to the very high vaccine coverage rate of 86 %.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 11-12/2012

Wiener Medizinische Wochenschrift 11-12/2012 Zur Ausgabe